$MAMA
Mama's Creations, Inc. Stock $mama

$mama Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223021060 Filed on June 13, 2023

Income Statement

Concept	2023 Q2	2022 Q2
Revenue	$23.12M	$21.83M
YoY Change	5.91%	111.67%
Cost Of Revenue	$16.75M	$18.12M
YoY Change	-7.56%	154.59%
Gross Profit	$6.371M	$3.710M
YoY Change	71.71%	16.09%
Gross Profit Margin	27.56%	17.0%
Selling, General & Admin	$4.357M	$3.423M
YoY Change	27.3%	47.51%
% of Gross Profit	68.39%	92.25%
Research & Development	$71.19K	$26.54K
YoY Change	168.22%	13.23%
% of Gross Profit	1.12%	0.72%
Depreciation & Amortization	$248.4K	$322.0K
YoY Change	-22.85%	75.23%
% of Gross Profit	3.9%	8.68%
Operating Expenses	$4.428M	$3.449M
YoY Change	28.38%	47.17%
Operating Profit	$1.943M	$261.0K
YoY Change	644.45%	-69.38%
Interest Expense	-$31.63K	-$124.3K
YoY Change	-74.54%	1091.28%
% of Operating Profit	-1.63%	-47.61%
Other Income/Expense, Net	-$162.9K	-$3.640K
YoY Change	4375.93%	-109.66%
Pretax Income	$1.780M	$133.1K
YoY Change	1237.44%	-84.87%
Income Tax	$524.7K	$29.39K
% Of Pretax Income	29.48%	22.08%
Net Earnings	$1.401M	$103.7K
YoY Change	1250.94%	-83.58%
Net Earnings / Revenue	6.06%	0.48%
Basic Earnings Per Share	$0.04	$0.00
Diluted Earnings Per Share	$0.04	$2.869K
COMMON SHARES
Basic Shares Outstanding	36.32M shares	35.76M shares
Diluted Shares Outstanding	37.63M shares	36.15M shares

Balance Sheet

Concept	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.259M	$921.3K
YoY Change	470.9%	-78.29%
Cash & Equivalents	$5.259M	$921.3K
Short-Term Investments
Other Short-Term Assets	$1.128M	$498.5K
YoY Change	126.23%	-1.19%
Inventory	$2.536M	$4.169M
Prepaid Expenses
Receivables	$8.389M	$8.999M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$17.31M	$14.59M
YoY Change	18.68%	47.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.320M	$7.171M
YoY Change	-53.7%	50.4%
Goodwill	$8.633M
YoY Change
Intangibles	$1.401M
YoY Change
Long-Term Investments	$1.489M
YoY Change
Other Assets	$1.919M	$471.4K
YoY Change	307.04%	-8.86%
Total Long-Term Assets	$18.50M	$18.15M
YoY Change	1.96%	237.77%
TOTAL ASSETS
Total Short-Term Assets	$17.31M	$14.59M
Total Long-Term Assets	$18.50M	$18.15M
Total Assets	$35.82M	$32.73M
YoY Change	9.41%	114.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.452M	$7.548M
YoY Change	25.21%	86.56%
Accrued Expenses	$409.0K	$359.9K
YoY Change	13.64%	106.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.428M	$2.486M
YoY Change	-2.35%	1242.58%
Total Short-Term Liabilities	$12.29M	$10.39M
YoY Change	18.22%	135.92%
LONG-TERM LIABILITIES
Long-Term Debt	$6.718M	$10.94M
YoY Change	-38.61%	2424.33%
Other Long-Term Liabilities	$2.845M	$3.184M
YoY Change	-10.64%	115.37%
Total Long-Term Liabilities	$9.563M	$14.13M
YoY Change	-32.3%	638.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.29M	$10.39M
Total Long-Term Liabilities	$9.563M	$14.13M
Total Liabilities	$21.85M	$24.52M
YoY Change	-10.88%	288.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.687M
YoY Change
Common Stock	$366.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$149.5K
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.96M	$8.214M
YoY Change
Total Liabilities & Shareholders Equity	$35.82M	$32.73M
YoY Change	9.41%	114.25%

Cashflow Statement

Concept	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$1.401M	$103.7K
YoY Change	1250.94%	-83.58%
Depreciation, Depletion And Amortization	$248.4K	$322.0K
YoY Change	-22.85%	75.23%
Cash From Operating Activities	$1.612M	-$1.343M
YoY Change	-220.01%	-193.6%
INVESTING ACTIVITIES
Capital Expenditures	$145.0K	-$174.0K
YoY Change	-183.34%	-50.9%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$145.0K	-$174.0K
YoY Change	-16.66%	-50.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$388.0K
YoY Change
Cash From Financing Activities	-$585.6K	1.588M
YoY Change	-136.88%	-5856.64%
NET CHANGE
Cash From Operating Activities	$1.612M	-1.343M
Cash From Investing Activities	-$145.0K	-174.0K
Cash From Financing Activities	-$585.6K	1.588M
Net Change In Cash	$881.1K	70.66K
YoY Change	1146.91%	-93.29%
FREE CASH FLOW
Cash From Operating Activities	$1.612M	-$1.343M
Capital Expenditures	$145.0K	-$174.0K
Free Cash Flow	$1.467M	-$1.169M
YoY Change	-225.46%	-165.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001520358
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	us-gaap	Notes Payable Current Related And Nonrelated Party Status Extensible Enumeration NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Notes Payable Current Related And Nonrelated Party Status Extensible Enumeration NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	us-gaap	Notes Payable Noncurrent Related And Nonrelated Party Status Extensible Enumeration NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Notes Payable Noncurrent Related And Nonrelated Party Status Extensible Enumeration NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2022Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2022Q2	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
CY2022Q2	MMMB	Payment Of Series B Preferred Dividends PaymentOfSeriesBPreferredDividends		usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q2	MMMB	Noncash Deposits On Prepaid Additions NoncashDepositsOnPrepaidAdditions		usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q2	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2022Q2	MMMB	Restricted Stock RestrictedStock		shares
CY2023Q2	MMMB	Incremental Common Shares Attributable To Warrants IncrementalCommonSharesAttributableToWarrants		shares
CY2022Q2	MMMB	Incremental Common Shares Attributable To Warrants IncrementalCommonSharesAttributableToWarrants		shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares		shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	000-54954
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	MamaMancini’s Holdings, Inc.
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0607116
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	25 Branca Road
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	East Rutherford
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07073
CY2023Q2	dei	City Area Code CityAreaCode	(201)
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	531-1212
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001
CY2023Q2	dei	Trading Symbol TradingSymbol	MMMB
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36484777	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5259448	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4378383	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8389108	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6832046	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2535831	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3635881	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1127631	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	828391	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	17312018	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	15674701	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3319698	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3423096	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1400614	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1502510	usd
CY2023Q2	us-gaap	Goodwill Goodwill	8633334	usd
CY2023Q1	us-gaap	Goodwill Goodwill	8633334	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3230896	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3236690	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	372361	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	717559	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	1489244	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1343486	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	57060	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	53819	usd
CY2023Q2	us-gaap	Assets Assets	35815225	usd
CY2023Q1	us-gaap	Assets Assets	34585195	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9451772	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9063256	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	54552	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	60082	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	1497172	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	1491642	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	408965	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	391802	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	180685	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	182391	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	750000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	750000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12288594	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11879091	usd
CY2023Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	750000	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	890000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2845326	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2897205	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	200467	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	248640	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1500000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	1500000	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	4267250	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	4655181	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9563043	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10191026	usd
CY2023Q2	us-gaap	Liabilities Liabilities	21851637	usd
CY2023Q1	us-gaap	Liabilities Liabilities	22070117	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	19680000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	19680000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36484777	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36484777	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36317857	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36317857	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	366	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	364	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22799322	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22724440	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8686600	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10060226	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	230000	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	230000	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	149500	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	149500	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13963588	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12515078	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35815225	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34585195	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23120816	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21830580	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16749816	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17970317	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	6371000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	3860263	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	71185	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26535	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4357031	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3572755	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4428216	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3599290	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1942784	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	260973	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	177394	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	124251	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5530	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3640	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	20000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-162924	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-127891	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1779860	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	133082	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	145758	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	524692	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29385	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1400926	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	103697	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	27300	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1373626	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103697	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36394033	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35759244	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37625518	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36148920	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12515078	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	55384	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19500	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	27300	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1400926	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13963588	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13963588	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8109818	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8109818	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	103697	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8213515	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8213515	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1400926	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	103697	usd
CY2023Q2	us-gaap	Depreciation Depreciation	248413	usd
CY2022Q2	us-gaap	Depreciation Depreciation	208829	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5530	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3640	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5794	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	69344	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101896	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	113170	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	55384	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	345198	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	29385	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	145758	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1557062	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1370867	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1100050	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1277898	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	607018	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	299864	usd
CY2023Q2	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-3241	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	696294	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1095439	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-34716	usd
CY2022Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-87888	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1611690	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1343013	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	145015	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	174007	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-145015	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174007	usd
CY2023Q2	MMMB	Repayments Of Term Loan RepaymentsOfTermLoan	387931	usd
CY2022Q2	MMMB	Repayments Of Term Loan RepaymentsOfTermLoan	129310	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-140000	usd
CY2022Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1775000	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	49879	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	58008	usd
CY2023Q2	MMMB	Payment Of Series B Preferred Dividends PaymentOfSeriesBPreferredDividends	-27300	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19500	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-585610	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1587682	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	881065	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	70662	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4378383	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	850598	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5259448	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	921260	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	152468	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	133291	usd
CY2023Q2	MMMB	Noncash Deposits On Prepaid Additions NoncashDepositsOnPrepaidAdditions	307778	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zPfmSctltYz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Note 1 - <span id="xdx_82D_zv1DSepKSoef">Nature of Operations and Basis of Presentation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation. The Company has a year-end of January 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our subsidiary, MamaMancini’s Inc., a Delaware Corporation (“Mamas”) is a marketer, manufacturer and distributor of beef meatballs with sauce, turkey meatballs with sauce, beef meat loaf, sausage & peppers, chicken parmesan and other similar meats and sauces. In addition, the Company continues to diversify its product line by introducing new products such as ready to serve dinners, single-size pasta bowls, bulk deli, packaged refrigerated products. Mamas products were submitted to the United States Department of Agriculture (the “USDA”) and approved as all natural. The USDA defines all natural as a product that contains no artificial ingredients, coloring ingredients or chemical preservatives and is minimally processed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 29, 2021, the Company made two acquisitions which expand the Company’s core product lines, and access to specific markets. T&L Creative Salads, Inc. (“T&L”) and Olive Branch, LLC (“Olive Branch”), are related premier gourmet food manufacturers based in New York. T&L offers a full line of foods for retail food chains and club stores, delis, bagel stores, caterers and provision distributors. T&L uses high-quality meats, seafood and vegetables, prepared to meet the standards set forth by the USDA and the Food and Drug Administration (“FDA”). Olive Branch started operations six years ago as a separate company to concentrate on selling olives, olive mixes, and savory products to a limited number of large retail customers, primarily in pre-packaged containers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 28, 2022, the Company acquired a <span id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember_zturOoR35bw2" title="Minority interest rate">24</span>% minority interest in Chef Inspirational Foods, LLC (“CIF”), a leading developer, innovator, marketer and sales company selling prepared foods, for an investment of $<span id="xdx_900_eus-gaap--Investments_iI_pn5n6_c20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember_zwQIHgpJBTO1" title="Investments">1.2</span> million. The investment consists of $<span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20220628__20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember_z7tW6C1qOeti" title="Investments in cash">500,000</span> in cash and $<span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember_znnsxb3F24Qa" title="Investments in common stock">700,000</span> in the Company’s common stock. The Company also was granted the option to purchase the remaining seventy-six percent (<span id="xdx_909_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_iI_pid_dp_uPure_c20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember_zeVMKa378eI8" title="Option to purchase remaining interest rate">76</span>%) interest in CIF within one year of June 28, 2022. The option purchase price is an additional $<span id="xdx_902_eus-gaap--Investments_iI_pn5n6_c20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember__srt--StatementScenarioAxis__custom--TwoYearFromAcquisitionDateMember_zKiIVvIotZA8" title="Investments">3.8</span> million, of which $<span id="xdx_90D_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20220628__20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember__srt--StatementScenarioAxis__custom--TwoYearFromAcquisitionDateMember_zBJpMkkNjwH1" title="Investments in cash">3.5</span> million would be paid in cash and $<span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20220628__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember__srt--StatementScenarioAxis__custom--TwoYearFromAcquisitionDateMember_z6eYfpHk2V93" title="Investments in common stock">300,000</span> in common stock, which would be paid within a two-year period fromthe date of the exercise of the option. The acquisition of the interest in CIF is being accounted for under the equity method of accounting for investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_esrt--ScheduleOfCondensedIncomeStatementTableTextBlock_zY89Q38nuyx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following presents the unaudited results of operations for the period February 1, 2023 through April 30, 2023 of CIF.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_z9RhnMVbcak7" style="display: none">Schedule of Results of Operations</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230201__20230430__us-gaap--BusinessAcquisitionAxis__custom--ChefInspirationalFoodsIncMember_zedIHsUBOBm6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period<br/> February 1, 2023<br/> through<br/> April 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zD96L7PGx9F1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">8,288,552</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLoss_zTQzHysH0Ydb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">607,324</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zVP0J9JW3ssd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z3I2SDeHxdN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zLXK8yDNSasc">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, the fair value of stock-based payments, inventory reserves, and estimates for unrealized returns, discounts, and other allowances that are netted against revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zzKnEn4mYOsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zI8uJ9JmP0j6">Risks and Uncertainties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has experienced, and in the future expects to continue to experience variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	4300000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	233000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	233000	usd
CY2023Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	32433	usd
CY2023Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	32433	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1296307	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1883270	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	93139	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	98910	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1146385	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1653701	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2535831	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3635881	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	71185	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26535	usd
CY2023Q2	MMMB	Gross Sales GrossSales	23599910	usd
CY2022Q2	MMMB	Gross Sales GrossSales	22348592	usd
CY2023Q2	MMMB	Sales Discount Returns And Allowances Goods SalesDiscountReturnsAndAllowancesGoods	479094	usd
CY2022Q2	MMMB	Sales Discount Returns And Allowances Goods SalesDiscountReturnsAndAllowancesGoods	518012	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23120816	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21830580	usd
CY2023Q2	MMMB	Gross Sales GrossSales	23599910	usd
CY2022Q2	MMMB	Gross Sales GrossSales	22348592	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	208570	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	187020	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	55384	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1373626	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103697	usd
CY2023Q2	us-gaap	Dilutive Securities DilutiveSecurities	27300	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1398926	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	103697	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36394033	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35759244	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	819000	shares
CY2023Q2	MMMB	Incremental Common Shares Attributable To Options IncrementalCommonSharesAttributableToOptions	277915	shares
CY2022Q2	MMMB	Incremental Common Shares Attributable To Options IncrementalCommonSharesAttributableToOptions	389677	shares
CY2023Q2	MMMB	Restricted Stock RestrictedStock	134570	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37625518	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36148920	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	372361	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	717559	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1400614	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2028639	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-526129	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5475527	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5387255	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	316956	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	284781	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3504629	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3480061	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9297112	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9152097	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5977414	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5729001	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3319698	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3423096	usd
CY2023Q2	us-gaap	Depreciation Depreciation	248413	usd
CY2022Q2	us-gaap	Depreciation Depreciation	208829	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2028639	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-628025	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1502510	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101896	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	113170	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	300237	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	400782	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	374216	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	325379	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1400614	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	367647	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.36
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	39773	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.76
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	407420	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.40
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	689000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.77
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	539000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.57
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	200000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.39
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	489000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.93
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	339000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.68
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.52
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	1.48
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	489000	shares
CY2023Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y11M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.93
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	339000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.68
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	544760	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	704450	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	200000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.39
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	166920	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19500	usd
CY2023Q2	us-gaap	Royalty Expense RoyaltyExpense	189484	usd
CY2022Q2	us-gaap	Royalty Expense RoyaltyExpense	150035	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	34716	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	87888	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	49879	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	58008	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M19D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M2D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M29D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0485	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0485	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0342	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0445	pure
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due Next Twelve Months LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	614997	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due Year Two LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	740687	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due Year Three LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	636946	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due Year Four LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	480626	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due Year Five LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFive	502983	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due After Year Five LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive	1331256	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Payments Due LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue	4307495	usd
CY2023Q2	MMMB	Lessee Operating And Finance Lease Liability Undiscounted Excess Amount LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	-672052	usd
CY2023Q2	MMMB	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	3635443	usd
CY2023Q2	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	Net Operating Losses (“NOLs”) generated in 2017 and prior years can be carried forward for 20 years. NOLs generated in 2018 – 2020, as enacted by the CARES Act, can be carried forward indefinitely. However, NOLs generated in 2021 are also carried forward indefinitely but limited to 80% of taxable income.
CY2023Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd

Files In Submission

Name	View Source	Status
mmmb-20230430_def.xml	Edgar Link	unprocessable
0001493152-23-021060-index-headers.html	Edgar Link	pending
0001493152-23-021060-index.html	Edgar Link	pending
0001493152-23-021060.txt	Edgar Link	pending
0001493152-23-021060-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4_005.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
mmmb-20230430.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
mmmb-20230430_lab.xml	Edgar Link	unprocessable
mmmb-20230430_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mmmb-20230430_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MAMA
Mama's Creations, Inc. Stock $mama

2023 Q2 Form 10-Q Financial Statement

#000149315223021060 Filed on June 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MAMA Mama's Creations, Inc. Stock $mama

2023 Q2 Form 10-Q Financial Statement

#000149315223021060 Filed on June 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MAMA
Mama's Creations, Inc. Stock $mama